Palvella Therapeutics (PVLA) Price to Sales (2015 - 2024)
Palvella Therapeutics' Price to Sales was 16.19 in Q3 2024, down 67.4% from 49.65 a year earlier.
Powered by 
Analysis
Palvella Therapeutics (PVLA) Price to Sales (2015 - 2024) Analysis & Trends
For FY2023, Price to Sales at Palvella Therapeutics came in at 33.65, down 85.9% from FY2022.
- In earlier years, Price to Sales was 239.36 in FY2022 (-65.6%), 695.15 in FY2021 (+82.0%), 381.97 in FY2020 (+10.6%) and 345.50 in FY2019 (-12.7%).
- Quarterly Price to Sales has moved between 0.47 (Q1 2024) and 1341.42 (Q3 2021) over five years.
- Compared with a year earlier, Price to Sales has declined for ten straight quarters, with an average decline of 79.1% over the last eight quarters.
- The best year-over-year quarter for Price to Sales over five years was Q3 2021 (growth of 547.2%); the worst was Q1 2024 (a decline of 99.9%).
- Per Business Quant data, PVLA's Price to Sales in the three quarters before Q3 2024 was 0.62 (Q2 2024), 0.47 (Q1 2024) and 33.57 (Q4 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Palvella Therapeutics | 1.91 Bn | 1.66 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | 16.19 |
| Jun 30, 2024 | 0.62 |
| Mar 31, 2024 | 0.47 |
| Dec 31, 2023 | 33.57 |
| Sep 30, 2023 | 49.65 |
| Jun 30, 2023 | 39.41 |
| Mar 31, 2023 | 378.40 |
| Dec 31, 2022 | 237.60 |
| Sep 30, 2022 | 238.59 |
| Jun 30, 2022 | 406.57 |
| Mar 31, 2022 | 666.13 |
| Dec 31, 2021 | 1,236.56 |
| Sep 30, 2021 | 2,451.47 |
| Jun 30, 2021 | 1,056.50 |
| Dec 31, 2020 | 381.97 |
| Sep 30, 2020 | 207.28 |
| Jun 30, 2020 | 228.35 |
| Mar 31, 2020 | 197.49 |
| Dec 31, 2019 | 345.50 |
| Sep 30, 2019 | 397.20 |
API Access
Palvella Therapeutics Price to Sales API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=price-to-sales&ticker=PVLA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "price-to-sales", "ticker": "PVLA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=price-to-sales&ticker=PVLA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();